GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.95
-0.05 (-0.28%)
Mar 24, 2026, 1:30 PM CST
Market Cap1.54B -12.5%
Revenue (ttm)401.23M +4.1%
Net Income57.20M -0.1%
EPS0.66
Shares Out86.01M
PE Ratio27.20
Forward PEn/a
Dividend0.80 (4.44%)
Ex-Dividend DateApr 8, 2026
Volume44,993
Average Volume75,367
Open18.10
Previous Close18.00
Day's Range17.80 - 18.20
52-Week Range17.20 - 23.00
Beta0.20
RSI46.08
Earnings DateMar 13, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan. It offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. The company was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2025, TPE:3164's revenue was 401.23 million, an increase of 4.11% compared to the previous year's 385.37 million. Earnings were 57.20 million, a decrease of -0.09%.

Financial Statements